Nanosphere Health Sciences Inc (NSHS.CX)
0.025
0.00 (0.00%)
CAD |
CNSX |
May 10, 16:00
Nanosphere Health Sciences Enterprise Value: 0.2414M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 10, 2024 | 0.2414M |
May 09, 2024 | 0.2414M |
May 08, 2024 | 0.2414M |
May 07, 2024 | 0.2414M |
May 06, 2024 | 0.2414M |
May 03, 2024 | 0.2414M |
May 02, 2024 | 0.2414M |
May 01, 2024 | 0.1387M |
April 30, 2024 | 0.1387M |
April 29, 2024 | 0.2414M |
April 26, 2024 | 0.2414M |
April 25, 2024 | 0.1901M |
April 24, 2024 | 0.1901M |
April 23, 2024 | 0.1901M |
April 22, 2024 | 0.1901M |
April 19, 2024 | 0.1901M |
April 18, 2024 | 0.1901M |
April 17, 2024 | 0.1901M |
April 16, 2024 | 0.1901M |
April 15, 2024 | 0.1901M |
April 12, 2024 | 0.1901M |
April 11, 2024 | 0.1901M |
April 10, 2024 | 0.1901M |
April 09, 2024 | 0.1901M |
April 08, 2024 | 0.1901M |
Date | Value |
---|---|
April 05, 2024 | 0.1901M |
April 04, 2024 | 0.1901M |
April 03, 2024 | 0.2414M |
April 02, 2024 | 0.2414M |
April 01, 2024 | 0.2414M |
March 28, 2024 | 0.2414M |
March 27, 2024 | 0.1901M |
March 26, 2024 | 0.1901M |
March 25, 2024 | 0.1901M |
March 22, 2024 | 0.1901M |
March 21, 2024 | 0.1901M |
March 20, 2024 | 0.1901M |
March 19, 2024 | 0.0873M |
March 18, 2024 | 0.0873M |
March 15, 2024 | 0.1387M |
March 14, 2024 | 0.1387M |
March 13, 2024 | 0.1387M |
March 12, 2024 | 0.1387M |
March 11, 2024 | 0.2414M |
March 08, 2024 | 0.2414M |
March 07, 2024 | 0.0873M |
March 06, 2024 | 0.0873M |
March 05, 2024 | 0.0873M |
March 04, 2024 | 0.0873M |
March 01, 2024 | 0.0873M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.0359M
Minimum
Nov 20 2023
30.00M
Maximum
May 14 2019
3.132M
Average
1.781M
Median
Enterprise Value Benchmarks
Biocure Technology Inc | 1.49M |
Core One Labs Inc | 9.986M |
Nova Mentis Life Science Corp | 1.447M |
Lobe Sciences Ltd | 1.892M |
Algernon Pharmaceuticals Inc | -- |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.0557M |
Total Expenses (Quarterly) | 0.0707M |
EPS Diluted (Quarterly) | -0.0054 |
Earnings Yield | -237.7% |
Normalized Earnings Yield | -4033.10 |